Seminars in Oncology
Volume 31, Issue 4 , Pages 465-475, August 2004

Pathology of upper gastrointestinal malignancies

  • Mario Sarbia

      Affiliations

    • Institute of Pathology, Technische Universität München, München, Germany
    • Corresponding Author InformationAddress reprint requests to Mario Sarbia, MD, Institute of Pathology, Technische Universität München, Ismaninger Straβe 22, 81675 München, Germany
  • ,
  • Karl Friedrich Becker

      Affiliations

    • Institute of Pathology, Technische Universität München, München, Germany
  • ,
  • Heinz Höfler

      Affiliations

    • Institute of Pathology, Technische Universität München, München, Germany

Abstract 

This review describes the most important macroscopic, histological, and molecular biological features of carcinomas of the esophagus, the gastroesophageal junction (GEJ), and the stomach. The three most frequent histological subtypes of upper GI tract carcinoma, ie, adenocarcinoma, squamous cell carcinoma, and small cell carcinoma, are considered. Important histological classifications of upper GI tract adenocarcinomas such as Lauren’s classification and the World Health Organization (WHO) classification, as well as rare histological variants of esophageal and gastric cancer, are described. Routes of tumor spread and principles of tumor classification are outlined. Furthermore, descriptions of the immediate precursor lesions of upper GI tract carcinomas, ie, dysplasias, are included. Finally, somatic genetic and epigenetic changes, which are associated with tumor development in the upper GI tract, are discussed.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(04)00241-6

doi:10.1053/j.seminoncol.2004.04.020

Seminars in Oncology
Volume 31, Issue 4 , Pages 465-475, August 2004